首页> 中文期刊> 《海南医科大学学报(英文版)》 >Treatment progress of brain metastases from lung cancer

Treatment progress of brain metastases from lung cancer

         

摘要

Objective:Lung cancer is one of malignant tumors with the highest incidence in the world, and 30%-65% of the patients develop brain metastases in the progression of the disease. Brain metastases seriously affect the patient's cognitive function, survival time and quality of life, the prognosis is extremely poor and the natural course of disease is about 1-3 months. The main therapies for brain metastases from NSCLC include surgical resection, radiotherapy, chemotherapy, and so on. In recent years, with the improvement of surgical methods, the improvement of radiotherapy technology, the emergence of targeted drugs and the combined use of various treatments, the survival time of patients has been greatly extended, and the quality of life has also been significantly improved. In this paper, the current main treatment strategies for brain metastases are reviewed.

著录项

  • 来源
    《海南医科大学学报(英文版)》 |2017年第8期|168-172|共5页
  • 作者

    Yan Fu; Shun-Chang Jiao; Nan Du;

  • 作者单位

    Oncology Department No. 2, First Affiliated Hospital of PLA General Hospital, Beijing, 100048;

    Medical Oncology Department, Chinese PLA General Hospital, Beijing, 100853;

    Medical Oncology Department, Chinese PLA General Hospital, Beijing, 100853;

    Oncology Department No. 2, First Affiliated Hospital of PLA General Hospital, Beijing, 100048;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号